LDS/Medical Tests/Follicular Lymphoma, bcl-2/JH t(14;18), FISH

Follicular Lymphoma, bcl-2/JH t(14;18), FISH

Follicular Lymphoma is a slow growing Non-Hodgkin’s Lymphoma (NHL) commonly diagnosed in older adults (50 and older). Follicular lymphoma (FL) is a mature B-cell neoplasm composed of follicle center (germinal center) lymphocytes that typically has at least a partially follicular histologic pattern.

Follicular lymphoma predominantly involves lymph nodes, but may affect spleen and bone marrow. Peripheral blood may also be affected, as well as non-hematopoietic extranodal sites such as the gastrointestinal tract, skin, and other organs. The disease is often slow growing and can be present for many years before it is diagnosed; however, most patients have widespread disease at the time of diagnosis. Follicular lymphoma is characterized by the chromosome translocation t(14;18)(q32;q21). The t(14;18)(q32;q21) translocation is a translocation of the bcl-2 gene on chromosome 18 to the IgH locus on chromosome 14, leading to over-expression of bcl-2, a proto-oncogene. This over-expression blocks normal apoptosis, leading to overgrowth of follicle center cells leading to lymphoma genesis. The t(14;18) translocation is characteristic of B-cell lymphomas, occurring in up to 90% of follicular lymphomas. It is also found in 20% to 30% of diffuse large B-cell lymphomas, where it is an indicator of poor prognosis. The bcl-2/JH assay is useful for establishing diagnosis, predicting prognosis, monitoring therapeutic response, and detecting minimum residual disease (MRD) or recurrent disease. The detection of a translocation, t(14;18), involving the BCL-2 proto-oncogene, would support this diagnosis. BCL-2 has also been implicated in the pathogenesis of non-lymphoma cancers including breast cancer, endometrial cancer, malignant melanoma, prostate cancer, and lung cancer.

  • Diagnosis of follicular B-cell lymphoma harboring bcl-2, t(14;18)
  • Disease management and treatment monitoring
  • Estimate prognosis, and recurrence for patients with B Cell Lymphoma
  • Monitor minimal residual disease (MRD); and predict early relapse
  • Evaluation for possible use of anti-sense nucleic acid therapy
A neoplastic clone is detected when the percent of cells with translocation or fusion bcl-2/JH t(14;18) exceeds the normal reference range for any given probe. Detection of bcl-2/JH t(14;18) translocation supports a diagnosis of Follicular Lymphoma.

Negative for t(14;18) translocation


 

Fluorescence in situ Hybridization (FISH).

Whole Blood EDTA (Lavender), Bone Marrow or Tissue

3-5 mL EDTA plasma. 5 mL Bone Marrow in EDTA, Fresh tissue RPMI media, Fresh frozen tissue in sterile container, Formalin Fixed Paraffin Embedded Tissue Block, Fine needle aspiration (lymph node biopsy).

Stability

  • Ambient:  1-3 days
  • Refrigerated: 3-5 days
Leukemia and Lymphoma immunophenotyping (Peripheral blood and bone marrow analysis by flow Cytometry), CCND1/IgH by flow Cytometry, t(14;18) Translocation by FISH, Chromosome Analysis.
5-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login